rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Helen M. Boudreau

Director

Company insider

Files Form 4 as: Director, Rallybio; Director, Shattuck Labs; Director, Premier; Director, Tvardi Therapeutics; Chief Financial Officer, Proteostasis Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
32
Buys
0
Sells
3
Bought
$0
Sold
$231K
Companies
5
Companies where not an officer
4
First trade
10 Feb 2016
Last trade
6 Jul 2026
Last filed
10 Jul 2026

Companies traded

Where they are an officer
Proteostasis TherapeuticsDirector, Officer · last 1 Mar 20180 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
RLYB RallybioDirector · Biotechnology · last 6 Jul 20260 buys · 0 sells
STTK Shattuck LabsDirector · Biotechnology · last 29 May 20260 buys · 0 sells
PremierDirector · last 25 Nov 20250 buys · 3 sells
TVRD Tvardi TherapeuticsDirector · Biotechnology · last 4 Jun 20240 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
6 Jul 2026filed 10 Jul 2026RLYB RallybioBiotechnologySEC FORM 4 Code M$8,4783,562 at $2.38filing
6 Jul 2026filed 10 Jul 2026RLYB Rallybiooption or derivative · BiotechnologySEC FORM 4 Code M—3,562 at $0.00filing
6 Jul 2026filed 10 Jul 2026RLYB Rallybiooption or derivative · BiotechnologySEC FORM 4 Code M—3,562 at $0.00filing
6 Jul 2026filed 10 Jul 2026RLYB RallybioBiotechnologySEC FORM 4 Code M$8,4783,562 at $2.38filing
29 May 2026filed 2 Jun 2026STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—81,000 at $0.00filing
29 May 2026filed 2 Jun 2026STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—81,000 at $0.00filing
25 Nov 2025filed 26 Nov 2025PremierSEC FORM 4 Code D$527K18,668 at $28.25filing
14 Jul 2025filed 16 Jul 2025STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—33,150 at $0.00filing
30 May 2025filed 2 Jun 2025PremierSEC FORM 4 Sold$46K2,000 at $22.88filing
13 May 2025filed 15 May 2025RLYB Rallybiooption or derivative · BiotechnologySEC FORM 4 Code A—28,500 at $0.00filing
6 Jan 2025filed 7 Jan 2025PremierSEC FORM 4 Sold$54K2,500 at $21.42filing
9 Dec 2024filed 10 Dec 2024PremierSEC FORM 4 Code A—7,101 at $0.00filing
21 Jun 2024filed 21 Jun 2024STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—27,700 at $0.00filing
4 Jun 2024filed 6 Jun 2024TVRD Tvardi Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—195,000 at $0.00filing
4 Jun 2024filed 6 Jun 2024TVRD Tvardi TherapeuticsBiotechnologySEC FORM 4 Code A—150,647 at $0.00filing
15 May 2024filed 17 May 2024RLYB Rallybiooption or derivative · BiotechnologySEC FORM 4 Code A—16,500 at $0.00filing
15 May 2024filed 16 May 2024PremierSEC FORM 4 Sold$132K6,629 at $19.85filing
4 Dec 2023filed 5 Dec 2023PremierSEC FORM 4 Code A—7,333 at $0.00filing
2 Aug 2023filed 4 Aug 2023TVRD Tvardi Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—155,747 at $0.00filing
26 May 2023filed 31 May 2023STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—40,258 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.